STANEK is a medication that combines two active ingredients, levodopa and carbidopa, in a specific formulation designed to manage symptoms of Parkinson's disease and parkinsonism. Levodopa is a precursor to dopamine, a neurotransmitter in the brain whose levels are decreased in patients with Parkinson's disease, leading to the characteristic symptoms of tremors, stiffness, and slowness of movement. Carbidopa is included to prevent the premature conversion of levodopa to dopamine outside the brain, ensuring more levodopa reaches the brain and reducing side effects like nausea. STANEK is typically prescribed to improve mobility and decrease the severity of Parkinson's disease symptoms, offering patients a better quality of life. It is important for patients to follow their healthcare provider's instructions closely when taking STANEK, as the dosing and timing relative to meals can significantly affect the medication's effectiveness and side effects profile.